HUTCHMED (China) (HMDCF) EBITDA Margin (QoQ) (2018 - 2021)
Powered by 
Analysis
HUTCHMED (China) (HMDCF) EBITDA Margin (QoQ) (2018 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -51,182.00 |
| Sep 28, 2021 | 44,330.00 |
| Jun 30, 2021 | -38,241.00 |
| Jun 30, 2020 | -17,606.00 |
| Mar 31, 2020 | 34,634.00 |
| Dec 31, 2019 | 78.00 |
| Sep 30, 2019 | 14,317.00 |
| Jun 30, 2019 | -28,510.00 |
| Mar 31, 2019 | 37,247.00 |
| Dec 31, 2018 | -32,851.00 |
| Sep 30, 2018 | -13,273.00 |
| Jun 30, 2018 | 20,568.00 |